Jun 24, 2025 7:00am EDT iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
Jun 23, 2025 4:15pm EDT iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call
Jun 24, 2025 8:30 am EDT iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates